Physician profile
Robert D Pearson
NPI 1295793834
$2,199.12
in general payments reported to CMS, 2019-2025
13 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.46 · 2020: $33.86 · 2021: $155 · 2022: $334 · 2023: $1,347 · 2024: $142 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $969 · Food and Beverage: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $968.91 |
| Food and Beverage | $658.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,628.59 | 2021-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $178.32 | 2022-2025 | |
| Resmed Corp | $74.50 | 2022-2025 | |
| Intersect Ent, INC. | $64.33 | 2019-2020 | |
| Optinose US, INC. | $43.20 | 2022 | |
| Xoran Technologies LLC | $40.12 | 2023 | Minicat |
| Regeneron Healthcare Solutions, INC. | $37.13 | 2023-2024 | Libtayo, Dupixent |
| Medtronic, INC. | $31.67 | 2024-2025 | Propel, Pteye Parathyroid Detection System |
| Genzyme Corporation | $30.88 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $18.99 | 2020 | |
| Lilly USA, LLC | $17.61 | 2025 | Zepbound, Mounjaro |
| Avadel Cns Pharmaceuticals, LLC | $17.43 | 2025 | Lumryz |
| Philips North America LLC | $16.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.